CTCFL (CCCTC-binding factor like)

2007-02-01  

Identity

HGNC
LOCATION
20q13.31
LOCUSID
ALIAS
BORIS,CT27,CTCF-T,HMGB1L1,dJ579F20.2

Other Information

Locus ID:

NCBI: 140690
MIM: 607022
HGNC: 16234
Ensembl: ENSG00000124092

Variants:

dbSNP: 140690
ClinVar: 140690
TCGA: ENSG00000124092
COSMIC: CTCFL

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000124092ENST00000243914Q8NI51
ENSG00000124092ENST00000371196Q8NI51
ENSG00000124092ENST00000422109Q8NI51
ENSG00000124092ENST00000422869Q8NI51
ENSG00000124092ENST00000423479Q8NI51
ENSG00000124092ENST00000426658F5H2V8
ENSG00000124092ENST00000429804Q8NI51
ENSG00000124092ENST00000432255Q8NI51
ENSG00000124092ENST00000433949Q8NI51
ENSG00000124092ENST00000481655V9GYX4
ENSG00000124092ENST00000502686Q8NI51
ENSG00000124092ENST00000539382Q8NI51
ENSG00000124092ENST00000608158V9GYX4
ENSG00000124092ENST00000608263Q8NI51
ENSG00000124092ENST00000608425V9GY73
ENSG00000124092ENST00000608440Q8NI51
ENSG00000124092ENST00000608720V9GZ46
ENSG00000124092ENST00000608903Q8NI51
ENSG00000124092ENST00000609232Q8NI51

Expression (GTEx)

0
1
2
3
4
5
6
7
8

Protein levels (Protein atlas)

Not detected
Low
Medium
High

References

Pubmed IDYearTitleCitations
369290512023BORIS variant SF2(C2/A4) promotes the malignant development of liver cancer by activating epithelial-mesenchymal transition and hepatic stellate cells.1
370828382023BORIS/CTCFL-mediated chromatin accessibility alterations promote a pro-invasive transcriptional signature in melanoma cells.0
372358392023Association of mutation and expression of the brother of the regulator of imprinted sites (BORIS) gene with breast cancer progression.0
369290512023BORIS variant SF2(C2/A4) promotes the malignant development of liver cancer by activating epithelial-mesenchymal transition and hepatic stellate cells.1
370828382023BORIS/CTCFL-mediated chromatin accessibility alterations promote a pro-invasive transcriptional signature in melanoma cells.0
372358392023Association of mutation and expression of the brother of the regulator of imprinted sites (BORIS) gene with breast cancer progression.0
335991912022Exploring the cancer-testis antigen BORIS to design a novel multi-epitope vaccine against breast cancer based on immunoinformatics approaches.17
348542382022Downregulation of BORIS/CTCFL leads to ROS-dependent cellular senescence and drug sensitivity in MYCN-amplified neuroblastoma.1
351320752022CTCFL regulates the PI3K-Akt pathway and it is a target for personalized ovarian cancer therapy.4
335991912022Exploring the cancer-testis antigen BORIS to design a novel multi-epitope vaccine against breast cancer based on immunoinformatics approaches.17
348542382022Downregulation of BORIS/CTCFL leads to ROS-dependent cellular senescence and drug sensitivity in MYCN-amplified neuroblastoma.1
351320752022CTCFL regulates the PI3K-Akt pathway and it is a target for personalized ovarian cancer therapy.4
334117042021Dynamic regulation of CTCF stability and sub-nuclear localization in response to stress.9
337562712021CTCFL expression is associated with cerebral vascular abnormalities.0
344264932021Pericentromeric noncoding RNA changes DNA binding of CTCF and inflammatory gene expression in senescence and cancer.31

Citation

Dessen P

CTCFL (CCCTC-binding factor like)

Atlas Genet Cytogenet Oncol Haematol. 2007-02-01

Online version: http://atlasgeneticsoncology.org/gene/43711/ctcfl